COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 2 of 3013 for:    Pancreatic Cancer

Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02581501
Recruitment Status : Withdrawn (Due to no enrollment, Celgene (sponsor) withdrew funding)
First Posted : October 21, 2015
Last Update Posted : April 18, 2019
Information provided by (Responsible Party):
Stamford Hospital

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016